{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:45:56Z","timestamp":1793508356331,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.1001\/jamaoncol.2021.2193","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T11:01:29Z","timestamp":1626346889000},"page":"1291","source":"Crossref","is-referenced-by-count":51,"title":["Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer"],"prefix":"10.1001","volume":"7","author":[{"given":"R. Charles","family":"Coombes","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom"},{"name":"Department of Digestion, Metabolism and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Tovey","sequence":"additional","affiliation":[{"name":"Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Kilburn","sequence":"additional","affiliation":[{"name":"Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Mansi","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 National Health Service Foundation Trust and Biomedical Research Centre, King\u2019s College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Palmieri","sequence":"additional","affiliation":[{"name":"University of Liverpool and Clatterbridge Cancer Centre, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Ontario Institute for Cancer Research, Toronto, Ontario, Canada"},{"name":"Edinburgh Cancer Research Centre, Edinburgh, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hicks","sequence":"additional","affiliation":[{"name":"National Health Service Lanarkshire, Lanarkshire, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Makris","sequence":"additional","affiliation":[{"name":"Mount Vernon Cancer Centre, Northwood, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Evans","sequence":"additional","affiliation":[{"name":"Breast Unit, Poole Hospital National Health Service Foundation Trust, Poole, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[{"name":"German Breast Group, Neu-Isenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[{"name":"Charit\u00e9 University Hospital and German Cancer Consortium, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Murray","sequence":"additional","affiliation":[{"name":"United Lincolnshire Hospitals National Health Service Trust, Lincolnshire, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Grieve","sequence":"additional","affiliation":[{"name":"University Hospitals Coventry and Warwickshire National Health Service Trust, Coventry, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Coleman","sequence":"additional","affiliation":[{"name":"University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Borley","sequence":"additional","affiliation":[{"name":"Velindre Cancer Centre, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Universitatsmedizin Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Rautenberg","sequence":"additional","affiliation":[{"name":"Universitatsklinikum Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina Alisa","family":"Kunze","sequence":"additional","affiliation":[{"name":"Charit\u00e9 University Hospital and German Cancer Consortium, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Rhein","sequence":"additional","affiliation":[{"name":"Stiftung Rehabilitation Heidelberg, Zentralkilikum Suhl GmbH, Suhl, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Mehta","sequence":"additional","affiliation":[{"name":"German Breast Group, Neu-Isenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Mousa","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom"},{"name":"Department of Digestion, Metabolism and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Dibble","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom"},{"name":"Department of Digestion, Metabolism and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Lou","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom"},{"name":"Department of Digestion, Metabolism and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"von Minckwitz","sequence":"additional","affiliation":[{"name":"German Breast Group, Neu-Isenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Bliss","sequence":"additional","affiliation":[{"name":"Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Tierbach","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bogle","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Badman","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Churn","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Newby","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Stickeler","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tranter","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Nichol","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C","family":"Winter","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Barthelmes","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wardley","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabha","family":"Chakrabarti","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmila","family":"Barthakur","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Hrouda","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pippa J","family":"Riddle","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Stewart","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Intrivici","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaz","family":"Walji","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pettit","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Lupton","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Woodings","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekharan","family":"Chandrasekharan","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Maxwell","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Simmonds","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Mehra","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medy","family":"Tsalic","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girija","family":"Anand","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozenn","family":"Allerton","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Shah","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Hadjiminas","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Maher","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Dhadda","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Bhatt","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran","family":"Venkitaraman","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Vinayan","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Taylor","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hatton","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Jones","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"McAdam","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Harding-MacKean","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Harries","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoba","family":"Silva","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Persic","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Vaidya","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rigg","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Wyld","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Hamed","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar S","family":"Shujja-Ud-Din","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Webster","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Wheatley","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Jafri","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Al-hasso","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazza","family":"Rehman","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon H","family":"Waters","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Fraser","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L","family":"Hayward","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta M","family":"Abraham","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Passant","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Wai-Ling King","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pope","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony I","family":"Skene","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C","family":"Scott","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majory K","family":"Maclennan","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W","family":"Rea","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola C","family":"Levitt","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Khan","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"H\u00f6nig","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Deutsch","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Hanusch","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Harbeck","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Lemster","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klein","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toralf","family":"Reimer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Gerd","family":"Meerpohl","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-J\u00fcrgen","family":"Winzer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"S\u00fcttmann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jackisch","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sallmann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klemm","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Schrader","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kamer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schem","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Liedtke","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roswitha","family":"Fuchs","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Thomssen","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Terhaag","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hitschold","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Wolf","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maring","family":"Carstensen","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Br\u00fcckner","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richter","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Gerber","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Burkamp","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Thomas","family":"Gra\u00dfhoff","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Simon","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk-Michael","family":"Zahm","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"von der Assen","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M","family":"Zahm","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Graffunder","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Bartzke","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Sommer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Neunh\u00f6ffer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Conrad","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Schulmeyer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Hofmann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Breitbach","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Scharl","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubomira","family":"Papez-Rodosek","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bender","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclhis","family":"Durmus","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Klare","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg-Uwe","family":"Deuker","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kn\u00f6rzer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich F","family":"Solomayer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Bischoff","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Stefek","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Prell","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Weiss","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Christoph","family":"Steffens","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Ober","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Emons","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Tesch","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Beckmann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bauer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hackmann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Bechler","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Langanke","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Weise","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Pelzl","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Ringel","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Schwarz","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunibert","family":"Latos","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Lampe","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem","family":"Siebers","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Heinrich","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Kleine-Tebbe","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schumacher","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Uleer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Kirste","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Heyl","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Katz","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Krabisch","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenci","family":"Palatty","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Gert","family":"H\u00f6ffkes","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Behrens","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Faust","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Gnauert","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Strittmatter","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Graf","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerold","family":"Baake","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Gatzweiler","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Sprengnetter","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Rezai","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Ufermann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lindner","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Rossmann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kunz","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Noesselt","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H","family":"Dewitz","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dietrich","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lerchenm\u00fcller","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Wagner","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Parisis","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Mattner","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Klutinus","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bechtner","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dall","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Scholz","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried B","family":"R\u00f6sel","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bettscheider","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Krauss","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Sawitzki","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Vehling-Kaiser","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Olbermann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk-Toralf","family":"Baerens","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Elisabeth","family":"Balwanz","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Schieder","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Peters","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Hahn","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehart","family":"Ladda","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Demandt","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Ackermann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christian","family":"Kolberg","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Seifert","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Berger","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kraudelt","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decker","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"H\u00e4nle","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Nacke","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Stauder","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christian","family":"Fricke","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kipp","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Stauter","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk P","family":"Ossenb\u00fchl","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Marx","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Hanf","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Schwoerer","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Dallacker","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hesse","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Denschlag","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Nestle-Kr\u00e4mling","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Buck","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donat","family":"Romann","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Dohnicht","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hornbacher","sequence":"additional","affiliation":[{"name":"for the Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"coi210034r1","first-page":"71","article-title":"Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.","volume":"6","author":"Harris","year":"1999","journal-title":"Oncol Rep"},{"issue":"2","key":"coi210034r2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","article-title":"Nonsteroidal antiinflammatory drugs and breast cancer.","volume":"7","author":"Harris","year":"1996","journal-title":"Epidemiology"},{"issue":"1","key":"coi210034r3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","article-title":"Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage.","volume":"83","author":"Sharpe","year":"2000","journal-title":"Br J Cancer"},{"issue":"10","key":"coi210034r4","first-page":"1679","article-title":"Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)\u2013selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.","volume":"3","author":"Elder","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"9","key":"coi210034r5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI119400","article-title":"Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.","volume":"99","author":"Sheng","year":"1997","journal-title":"J Clin Invest"},{"key":"coi210034r6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology.","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"issue":"52","key":"coi210034r7","doi-asserted-by":"publisher","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","article-title":"Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2.","volume":"271","author":"Smith","year":"1996","journal-title":"J Biol Chem"},{"issue":"7","key":"coi210034r8","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1073\/pnas.88.7.2692","article-title":"Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.","volume":"88","author":"Xie","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"coi210034r9","doi-asserted-by":"publisher","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","article-title":"TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase\/cyclooxygenase homologue.","volume":"266","author":"Kujubu","year":"1991","journal-title":"J Biol Chem"},{"issue":"3","key":"coi210034r10","first-page":"503","article-title":"Cyclooxygenase-2 gene expression in human breast cancer.","volume":"10","author":"Parrett","year":"1997","journal-title":"Int J Oncol"},{"issue":"12","key":"coi210034r11","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1002\/(ISSN)1097-0142","article-title":"COX-2 is expressed in human pulmonary, colonic, and mammary tumors.","volume":"89","author":"Soslow","year":"2000","journal-title":"Cancer"},{"issue":"21","key":"coi210034r12","doi-asserted-by":"publisher","first-page":"18563","DOI":"10.1074\/jbc.M010787200","article-title":"Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.","volume":"276","author":"Liu","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"coi210034r13","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/cncr.v97:12","article-title":"Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.","volume":"97","author":"Denkert","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"coi210034r14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10549-010-0854-7","article-title":"COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients.","volume":"125","author":"van Nes","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"1-2","key":"coi210034r15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0304-3835(99)00050-6","article-title":"Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.","volume":"140","author":"Brueggemeier","year":"1999","journal-title":"Cancer Lett"},{"issue":"9196","key":"coi210034r16","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"coi210034r17","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial.","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"coi210034r18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-142-7-200504050-00113","article-title":"The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.","volume":"142","author":"L\u00e9vesque","year":"2005","journal-title":"Ann Intern Med"},{"issue":"7","key":"coi210034r19","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Selective cyclooxygenase 2 inhibitors and cardiovascular events.","volume":"52","author":"Solomon","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"20","key":"coi210034r20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"coi210034r21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"coi210034r24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/jnci\/djy017","article-title":"Effects of celecoxib and low-dose aspirin on outcomes in adjuvant aromatase inhibitor\u2013treated patients: CCTG MA.27.","volume":"110","author":"Strasser-Weippl","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"coi210034r25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ejca.2017.01.008","article-title":"Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status.","volume":"75","author":"Giacchetti","year":"2017","journal-title":"Eur J Cancer"},{"issue":"5","key":"coi210034r26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1158\/1940-6207.CAPR-15-0311","article-title":"A randomized, placebo-controlled, phase II, presurgical biomarker trial of celecoxib versus exemestane in postmenopausal breast cancer patients.","volume":"9","author":"Aristarco","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"coi210034r27","first-page":"1485","article-title":"COX2\/PTGS2 expression is predictive of response to neoadjuvant celecoxib in HER2-negative breast cancer patients.","volume":"38","author":"De Cremoux","year":"2018","journal-title":"Anticancer Res"},{"issue":"2","key":"coi210034r28","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/bcr3409","article-title":"A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.","volume":"15","author":"Brand\u00e3o","year":"2013","journal-title":"Breast Cancer Res"},{"issue":"3","key":"coi210034r29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-008-0229-5","article-title":"Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study.","volume":"116","author":"Falandry","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"coi210034r30","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1200\/JCO.2007.13.3744","article-title":"Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib.","volume":"26","author":"Dirix","year":"2008","journal-title":"J Clin Oncol"},{"key":"coi210034r31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"coi210034r32","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity.","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"issue":"3","key":"coi210034r34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00228-007-0400-7","article-title":"Clinical use and pharmacological properties of selective COX-2 inhibitors.","volume":"64","author":"Shi","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"coi210034r33","author":"Tovey"},{"key":"coi210034r22","unstructured":"Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Published August 9, 2006. Accessed June 7, 2021. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf"},{"key":"coi210034r23","unstructured":"MedDRA. Medical Dictionary for Regulatory Activities. Accessed June 7, 2021. https:\/\/www.meddra.org\/"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2781890\/jamaoncology_coombes_2021_oi_210034_1631288549.31406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T11:07:52Z","timestamp":1631790472000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2781890"}},"subtitle":["The REACT Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.2193","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}